REGENXBIO Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio10.94
Forward P/E76.17
P/S Ratio4.608.758.712.9710.98
P/B Ratio1.482.531.901.834.49
Price/Tangible Book1.482.531.901.834.49
Price/FCF10.38
Price/OCF6.39
Enterprise Value Ratios
EV/Revenue3.006.895.332.409.50
EV/EBITDA6.67
EV/EBIT7.06
EV/FCF8.39
Profitability & Returns
Return on Equity (ROE)-0.79%-0.64%-0.44%0.22%-0.27%
Return on Assets (ROA)-0.28%-0.23%-0.16%0.11%-0.12%
Return on Invested Capital (ROIC)-1.20%-0.88%-0.54%0.40%-0.72%
Return on Capital Employed (ROCE)-0.64%-0.60%-0.36%0.16%-0.19%
Leverage & Solvency Ratios
Debt/Equity0.550.590.450.340.70
Debt/EBITDA1.42
Debt/FCF1.92
Liquidity Ratios
Current Ratio2.692.573.193.986.52
Quick Ratio2.592.453.083.736.37
Efficiency Ratios
Asset Turnover0.160.130.120.520.26
Yield & Distribution Ratios
Earnings Yield-0.59%-0.33%-0.29%0.09%-0.07%
FCF Yield-0.46%-0.29%-0.24%0.10%-0.05%
Buyback Yield-0.13%-0.01%0.02%-0.18%-0.02%